PLEXPLUS

Serial Number 79337468
Registration 7057884
700

Registration Progress

Application Filed
Sep 27, 2021
Under Examination
Approved for Publication
Mar 7, 2023
Published for Opposition
Mar 7, 2023
Registered
May 23, 2023

Trademark Image

PLEXPLUS

Basic Information

Serial Number
79337468
Registration Number
7057884
Filing Date
September 27, 2021
Registration Date
May 23, 2023
Published for Opposition
March 7, 2023
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
700
Status Date
May 23, 2023
Registration
Registered
Classes
001 005 010 042
+1 more

Rights Holder

SpeeDx Pty Ltd

82
Address
Suite G16, National Innovation Centre,
Australian Technology Park, 4 Cornwallis
AU

Ownership History

SpeeDx Pty Ltd

Original Applicant
82
AU

SpeeDx Pty Ltd

Owner at Publication
82
AU

SpeeDx Pty Ltd

Original Registrant
82
AU

Legal Representation

Attorney
Joi A. White

USPTO Deadlines

Next Deadline
1408 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-05-23)
Due Date
May 23, 2029
Grace Period Ends
November 23, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

38 events
Date Code Type Description Documents
Sep 17, 2023 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Aug 28, 2023 FIMP P FINAL DISPOSITION PROCESSED Loading...
Aug 28, 2023 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Aug 23, 2023 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
May 23, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
May 23, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Mar 7, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 7, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 6, 2023 GPNX P NOTIFICATION PROCESSED BY IB Loading...
Feb 15, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 15, 2023 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Loading...
Feb 15, 2023 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Jan 27, 2023 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jan 27, 2023 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Jan 27, 2023 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jan 27, 2023 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jan 27, 2023 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 19, 2023 ZZZX Z PREVIOUS ALLOWANCE COUNT WITHDRAWN Loading...
Jan 17, 2023 PBCR Z WITHDRAWN FROM PUB - OG REVIEW QUERY Loading...
Dec 30, 2022 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 29, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 28, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Dec 28, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 12, 2022 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Dec 12, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Dec 12, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Dec 12, 2022 ECDR I TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Loading...
Dec 12, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Dec 12, 2022 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jul 20, 2022 RFNT P REFUSAL PROCESSED BY IB Loading...
Jun 29, 2022 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Jun 29, 2022 RFRR P REFUSAL PROCESSED BY MPU Loading...
Jun 29, 2022 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Jun 28, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 28, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Apr 12, 2022 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Apr 8, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 7, 2022 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 001
Chemicals used in industry and science; chemical preparations for use in photography; chemicals for use in agriculture, horticulture and forestry except fungicides, herbicides, insecticides and parasiticides; reagents and reactants in this class for scientific and research use, medical research use, and nonmedical use; enzymes for industrial or scientific purposes; nucleic acid for other than medical and veterinary purposes; nucleic recombinant acid for other than medical and veterinary purposes; acids namely inorganic acids for industrial purposes; DNA polymerase; chemicals used in food processing and screening; chemicals used in environmental monitoring
First Use Anywhere: 0
First Use in Commerce: 0
Class 005
Pharmaceutical and veterinary preparations and substances consisting of catalytic DNA molecules and associated detection reagents for the diagnosis of diseases, for detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolite expression, inflammation, and immune-suppression and immune disorders, for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, and for analysis of response to therapy; reagents for medical and veterinary use; nucleic acid amplification reagents for medical use; nucleic acid sequencing preparations for medical use; chemical preparations containing enzymes for medical purposes for the diagnosis of diseases or detection or identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy; chemical preparations containing enzymes for pharmaceutical, veterinary and medical purposes for the diagnosis of diseases or detection or identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy; enzymes for pharmaceutical, veterinary and medical purposes for the diagnosis of diseases or detection or identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy; medical kits containing medical and/or pharmaceutical preparations and associated detection reagents for the diagnosis of diseases, for detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolite expression, inflammation, and immune-suppression and immune disorders, for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, and for analysis of response to therapy; clinical diagnostic preparations for medical or veterinary use; biological chemical diagnostic test kits comprised of reagents and assays for medical laboratory use in analysis that test for the presence of gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders
First Use Anywhere: 0
First Use in Commerce: 0
Class 010
Surgical apparatus and instruments; medical and veterinary apparatus and instruments being diagnostic testing apparatus and instruments for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy; diagnostic testing apparatus and instruments for medical purposes; diagnostic testing kits consisting primarily of diagnostic testing apparatus and instruments for the purpose of detecting antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy; point of care medical devices being diagnostic testing apparatus for the purpose of detecting antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy; medical screening kits comprised of medical screening and testing apparatus for the diagnosis of disease, detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired and inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy; biological chemical test kits for medical laboratory use in analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders
First Use Anywhere: 0
First Use in Commerce: 0
Class 042
Scientific and technological services and research and design relating thereto, namely, DNA analysis services for scientific research purposes, scientific research consulting in the field of genetics; scientific research in the field of genetics; genetic engineering services for scientific purposes; scientific research in the field of genetics and genetic engineering; scientific research relating to genetics; chemistry services; research relating to chemistry; scientific research relating to chemistry; research in the field of chemistry; laboratory analysis in the field of chemistry; development of medical diagnostic apparatus; design of medical diagnostic apparatus; research relating to molecular sciences; analysis of data generated by scientific and medical experiments and tests; biological, bacteriological, chemical, biochemical, dna, rna, protein, polynucleic acid and molecular analysis and evaluation services; dna and rna and polynucleic acid and protein sequencing, analysis and evaluation services; genome sequencing services and the analysis and evaluation of data resulting therefrom; provision of reports relating to scientific and medical experiments, the results of scientific and medical experiments and tests, the analysis and evaluation of scientific and medical data, and data generated by scientific and medical experiments and tests; scientific and medical research and development services in the field of the diagnosis of disease, detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy; custom design and development of biochemical assays
First Use Anywhere: 0
First Use in Commerce: 0
Class 044
Medical services; human healthcare services; medical testing services relating to the diagnosis and treatment of disease; genetic testing for medical purposes; medical and health services relating to dna, genetics and genetic testing; medical diagnostic services in the nature of medical testing and medical analysis; providing collected and analysed medical information in the field of genetic and treatment information for diseases and disorders for diagnostic and treatment purposes; medical diagnostic imaging and molecular medicine; molecular medical diagnostics testing
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Pseudo Mark
PLEX PLUS

Classification

International Classes
001 005 010 042 044